Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Medical Informatics

Date Submitted: Oct 13, 2025
Date Accepted: Jun 3, 2026

The final, peer-reviewed published version of this preprint can be found here:

Pre-Amyloidosis Red-Flag Clinical Diagnoses in Light Chain (AL) Versus Age-Related Transthyretin (ATTRwt) Amyloidosis: Electronic Health Record–Based Descriptive Study

Estrada-Merly N, Pezzin LE, Sparapani R, D'Souza A

Pre-Amyloidosis Red-Flag Clinical Diagnoses in Light Chain (AL) Versus Age-Related Transthyretin (ATTRwt) Amyloidosis: Electronic Health Record–Based Descriptive Study

JMIR Med Inform 2026;14:e85803

DOI: 10.2196/85803

PMID: 42330197

Pre-amyloidosis red-flag clinical diagnoses in light chain (AL) versus age related transthyretin (ATTRwt) amyloidosis: Electronic Health Record–based descriptive study

  • Noel Estrada-Merly; 
  • Liliana E. Pezzin; 
  • Rodney Sparapani; 
  • Anita D'Souza

ABSTRACT

This study analyzed electronic health records to identify distinct early clinical patterns in AL and ATTRwt amyloidosis, highlighting opportunities for earlier diagnosis through red-flag symptom recognition.


 Citation

Please cite as:

Estrada-Merly N, Pezzin LE, Sparapani R, D'Souza A

Pre-Amyloidosis Red-Flag Clinical Diagnoses in Light Chain (AL) Versus Age-Related Transthyretin (ATTRwt) Amyloidosis: Electronic Health Record–Based Descriptive Study

JMIR Med Inform 2026;14:e85803

DOI: 10.2196/85803

PMID: 42330197

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.